Laboratory infarction diagnostics are based on the detection of elevated serum activities of total Creatine Kinase (CK), Creatine Kinase isoensyme MB,(CKMB), Lactate dehydrogenase (LDH), isoenzyme forms of LDH and transaminases. Determination of these cardiac marker enzymes permits a highly sensitive diagnosis of transmural myocardial infarction. In such patients the diagnosis of acute myocardial infarction can be confirmed by the clinical symptoms, and changes in the ECG in addition to the enzyme assays. The 50 AMI patients selected in the present study were those admitted to the ICCU of Shri Krishna Hospital, Karamsad. The blood samples were taken at the time of admission (ie. within four hours of the start of chest pain). The samples were analyzed for CK, CKMB, SGOT,(Serum glutamate oxaloactate transaminase) (~HBDH o~ -hydroxybutyrate dehydrogenase and troponin T. The serum CKMB activity in AMI showed an increase only 5-6 hours after the commencement of chest pain. The elevation in SGOT and ocHBDH was still delayed. At the same time we could observe that the cardiac Troponin T (cTnT) was elevated at the time of admission of the patient itself. This increase of cTnT in AMI patients was 20 times higher than the normal blood donors. The controls included 25 normal blood donors and 25 patients with polytraumatic injuries with no chest contusion. The study shows that cTnT estimation could serve in the early diagnosis of AMI. The increase of cardiac troponin T in AMI patient was 20 times higher than the normal blood donors in AMI patients at the time of admission. Cardiac troponin T in serum appears to be a more sensitive indicator of myocardial cell injury than CKMB activity and its detection in the circulation may be a useful prognostic indicator in patients with unstable angina as well. When the blood of normal blood donors or that of patients with polytraumatic injury was analysed the troponin T values were well within the normal range in both the above categories showing that cardiac troponin T is highly specific for heart tissue .Although CKMB and cardiac troponin T are released soon after the myocardial injury, the release of cardiac troponin T is much earlier than CKMB thereby invalidating the important role of cardiac troponin T in diagnosing AMI. Cardiactroponin T has been shown to be highly sensitive for cardiac injury and not elevated in any other trauma, heavy exercise or skeletal muscle injury.Cardiac troponin T is ordinarily undetectable in healthy individuals, and so its measurement can serve as a powerful tool in the diagnosis of AMl.
INTRODUCTION
The transmural infarction diagnosis can be achieved by ECG changes and the elevation of cardiac enzyme markers. Neverthless, there are problems with the diagnosis of small myocardial infarctions which are comparable in importance with the transmural infarctions. The ECG offers little help in such cases and the sensitivity of the laboratory parameters like CK, Creatine phospokinase isoenzyme MB (CKMB), LDH, and Alpha Hydroxybutyrate Dehydrogenase (HBDH) is not adequate because of the variation in normal serum levels and of the short-lasting and small increases in their serum activities after such events. Of course, the same applies to patients with unstable angina pectods also.
The available diagnostic parameters are also unsatisfactory in patients with multiorgan diseases or with additional skeletal muscle lesions, because in such cases a definite differentiation of skeletal muscle and heart muscle necrosis is impossible because of the organ distdbution of CK, LDH or their isoforms. The CKMB values are seen to be elevated only 5-6 hours after the chest pain has begun. Hence an eady cardiac marker of AMI shall be greatly welcome.
In addition to the diagnosis of acute myocardial infarction the laboratory parameters are of major importance in monitoring the course of the infarction and in estimating the infarct size. Cytosol proteins such as CK are washed out in different percentages in dependence on the blood flow in the early phase of the infarction and therefore appear eadier in the reperfused infarct, and their plasma activities are higher than in the case of non-reperfused infarcts.
A new immunoassay for cTnT which eliminates most of the earlier shortcomings of laboratory infarction diagnostics was planned to be carried out to evaluate the utility value of Troponin T in eady diagnosis of AMI. Such studies have been scanty on Indians.
MATERIALS AND METHODS
The study carried out incorporates the serial estimations of different cardiac enzyme markers in the sera of patients having myocardial infarction. They were admitted to the ICCU of Shri Kdshna Hospital, Karamsad. The first blood sample was collected at zero hours (i.e. at the time of admission of the patient). All the patients admitted within 5 hours of the starting of chest pain were included in the study. 1.5 million units of Streptokinase was mixed with 100 to 150 ml of normal saline and was administered by intraveneous infusion over a period of one hour to these patients soon after their admission. The blood samples were collected in vials containing no anticoagulant or preservative. The samples were collected using a disposable needle and syringe and care was taken to get non hemolysed samples. The serum samples were analyzed for CK, CKMB, SGOT, o~HBDH and Troponin T. The study compdsed of 50 patients with AMI out of which 12 were females and 38 were males. Twenty five subjects were selected from normal blood donors and another 25 subjects with polytraumatic injury without any chest or cardiac ailment were also included in the study to serve as controls. Well standardised methods were used for the estimation of CK, CKMB, SGOT, o~HBDH and Troponin T (1) (2) (3) (4) (5) , The serum Cardiac Troponin T concentration was measured using the reagent kit manufactured by Boehringer Mannheim based on enzyme linked immunoassay.
RESULTS
The results of the present study are given in tables 1 to 3 and graphs 1 to 2.
DISCUSSION
The diagnosis of acute myocardial infarction (AMI) (6) has traditionally been based on the characteristic clinical history, electrocardiographic abnormalities and increased serum concentrations of cardiac marker enzymes. As the differential diagnostic value of chest pain is limited (6) and the electrocardiographic changes have various degrees of sensitivity and specificity (7-9), the measurements of serum enzymes as a reflection of damage to myocardial muscle cells still play an important role in the diagnosis of AMI. Measurements of creatine kinase (CK), aspartate aminotransferase, and lactate dehydrogenase are well-established methods for this. Considerable effort has been made in recent years to improve the specificity and sensitivity of methods for diagnosing AMI. Myoglobin is an early and sensitive marker of cardiac cell damage but lacks specificity (10) . The use of LDH isoenzyme 1 improves Specifit:ity in diagnosing AMI; however, this isoenzyme is not restricted to cardiac muscle tissue, and increase in its serum concentration has been observed in noncardiac conditions also (11). Clinicians would therefore benefit from the introduction of a new cardiac specific marker of damage to myocardial muscle cells. The contractile and regulatory proteins of the myocardium provide such a useful diagnostic tool. Troponin T (TnT) is a part of the troponin complex in striated muscles, where it binds the troponin complex to tropomyosin. Although both cardiac and skeletal muscles contain TnT, the amino acid sequence of the protein in the two types of muscles differs (12,13), making it possible to raise antisera against cardiac-specific TnT. The high specificity and sensitivity of cardiac TnT in diagnosing and monitoring AMI had been demonstrated by Johannes Mair et a/(14) .
Several epidemiological studies have established various factors which increase the risk of developing myocardial infarction. The cardinal risk factors identified in AMI are hypercholestemlemia, systemic arterial hypertension, smoking, obesity, sedentary habits and consumption of a largely high saturated fat diet. I~ the present study smoking was found to be associated with 18.4% of patients with acute myocardial infarction. Amongst the male patients seven were chrcnic smokers. All of them were below 50 years of age. This might point towards the deleterious effect of smoking in causing early AMI. Our study is in agreement with Paul M. Ridker (1) who found 13.9% of patients in his study were smokers.
Troponin Tis a part of the regulatory system of the contractile complex of skeletal and heart muscle. It is expressed in two different isoforms, namely skeletal muscle troponin T and cardiac troponin T. After loss of the integrity of the cell membrane, it is released into the circulation similar to myoglobin or creatine kinase (8). Because cardiac troponin T is ordinarily undetectable in healthy individuals (9) its measurement is a powerful tool in the diagnosis of acute myocardial infarction. Moreover, about onethird of patients with unstable angina pectoris show increased cardiac troponin T in serum (10) . These patients may be a subgroup with a high risk for complications i.e. acute myocardial infarction (11). After myocardial cell necrosis an increased concentration of cTnT is observable in blood for more than a week (12). Thus cardiac Troponin T measurement is particularly useful in clinical circumstances in which traditional enzyme determiations fail to diagnose myocardial cell damage efficiently (13-'15) . Given the high sensitivity of cardiac Troponin T measurements, the [93] [94] [95] [96] [97] [98] [99] [100] [101] authors (16) were interested to know whether determination of cTnT may be useful for the noninvasive detection of myocardial cell damage in patients with acute myocarditis. The diagnosis of myocardial muscle cell damage is generally based on the patient's clinical history, electrocardiogram and enzyme concentrations in serum, especially creatine kinase isoenzyme MB. The concentration of CKMB is higher in myocardium than in other tissues, but the protein is also present in skeletal muscles (17) . Pathological values for CKMB in serum can therefore be seen in some instances of skeletal muscle damage e.g. with heavy physical exercise (18). Skeletal muscle damage has been postulated to be the most likely reason for increased CKMB in serum of athletes, where the possibility of simultaneous release of CKMB from both heart and skeletal muscle could not be excluded.
Among many available serological tools for detecting acute myocardial infarction, the determination of the MB isoenzyme of creatine kinase provide the highest diagnostic efficiency (16) (17) (18) (19) . Therefore, CKMB determinations are generally regarded asthe reference standard for diagnostic tests forAMl. Yet variable normal serum levels of CKMB (20) (21) (22) and its brief elevation in serum during the course of myocardial infarction (23) (24) (25) , limit the diagnostic value of CKMB determinations. In practice, physicians are sometimes left with patients in whom definitive diagnosis of myocardial infarction cannot be made by CKMB measurements and an alternative test of even greater sensitivity and specificity is needed. The data of their study indicate that the newly developed troponin T test improves the efficiency of serodiagnostic tools for the detection of myocardial cell necrosis as compared with conventionally used cardiac enzymes (25). Our study is in good agreement with the above observations and further confirms the utility value of cardiac troponin T in AMI detection.
In our study of 50 patients with AMI, 42 showed only slightly elevated levels of CK (p < 0.005) at the time of admission (at zero hours), but eight patients had CK values within the normal range. At the same time in all the patients, the CKMB values were within the normal range at thetime of admission (p < 0.05) showing that for very early detection of AMI (i.e. within 3 to 4 hours after the onset of chest pain), the CKMB alone may not be helpful. When CK and CKMB estimations were carded out at 6 hours a~er the admission of the patient both were found to be significantly increased (P < 0.001). CKMB elevation in our study took place only six hours after the admission of the patient. There was further increase of CKMB at 14 hours.
Further in our study the pattern of changes in the concentrations of AST and o~HBDH showed variation from that of C;K and CKMB. Both AST and ~HBDH were also normal at zero hours. (i.e. at the time of admission). The AST and ~HBDH values started rising at six hours and exhibited further rise at 14, 32 and 48 hours. These observations of ours are comparable to the studies reported by other authors (26).
According to Katus et al (1993) Troponin T is elevated more than twice the analytical sensitivity of the assay (0.5 ng/ml) in all patients with infarction Troponin T appeared in the serum as early as 3 hours after the onset of chest pain in 50% of patients and remained elevated in all patients for more than 130 hours. The diagnostic efficiency of troponin T was superior to that of CKMB and remained elevated for 5 89 days after admission. In our study the troponin T values were found to be increased in all the patients at zero hours at the time of admission of the patient. Where as CKMB levels were within the normal limits We also observed that there was a steep rise in the troponin T values at 6 and 14 hours after giving streptokinase to the patients showing very good reperfusion. Further, we made the following observations from our studies.
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The increase of cardiac treponin T was 20 times higher than the normal blood donors in AMI patients at the time of admission.
9 Cardiac treponin T in serum appears to be a more sensitive indicator of myocardial cell injury than CKMB activity and its detection in the circulation may be a useful prognostic indicator in patients with unstable angina as well.
When the blood of normal blo~l donors or that of patients with polytraumatic injury was analysed the treponin T values were well within the normal range in both the above categones showing that cardiac treponin T is highly specific for heart tissue.
Although CKMB and cardiac troponin T are released soon after the myocardial injury, the release of cardiac troponin T is much earlier than CKMB thereby invalidating the important role of cardiac troponin T in diagnosing AMI. 
